Valuation: DBV Technologies

Market Cap 850M 972M 784M 726M 1.38B 92.24B 1.4B 9.4B 3.65B 45.52B 3.65B 3.57B 157B P/E 2026 *
-7.48x
P/E 2027 * -21x
Enterprise Value 775M 886M 715M 662M 1.26B 84.09B 1.28B 8.57B 3.33B 41.5B 3.33B 3.25B 143B EV / Sales 2026 *
206x
EV / Sales 2027 * 10.5x
Free-Float
53.86%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: DBV Technologies

Manager TitleAgeSince
Chief Executive Officer 66 28/11/2018
Director of Finance/CFO 56 05/11/2023
Chief Operating Officer - 30/11/2023
Director TitleAgeSince
Director/Board Member 51 20/10/2015
Director/Board Member 62 20/06/2016
Director/Board Member 60 14/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 972M
-1.61%+0.65%+55.08%+14.76% 318B
-1.27%-3.15%+25.40%-4.05% 70.43B
-1.98%+4.03%+43.57%+114.66% 9.68B
-1.29%+3.58%+7.01%+2.10% 8.78B
+1.07%-6.81%-7.11%+9.27% 4.39B
-5.65%+0.56%+11.76%+23.41% 4.01B
+1.01%-4.74%-33.99%+27.27% 3.46B
-0.49%+1.01%+49.24%+60.54% 2.78B
-2.91%-1.09%+13.77%-21.96% 2.16B
Average -1.33%-0.41%+18.30%+25.11% 47.1B
Weighted average by Cap. -1.54%-1.94%+46.86%+13.89%

Financials

2026 *2027 *
Net sales 3.77M 4.31M 3.48M 3.22M 6.12M 409M 6.21M 41.68M 16.21M 202M 16.18M 15.83M 698M 80.26M 91.72M 73.97M 68.56M 130M 8.71B 132M 887M 345M 4.3B 344M 337M 14.85B
Net income -151M -172M -139M -129M -245M -16.36B -249M -1.67B -648M -8.07B -647M -633M -27.91B -104M -118M -95.49M -88.5M -168M -11.24B -171M -1.14B -445M -5.55B -445M -435M -19.17B
Net Debt -75.08M -85.8M -69.19M -64.13M -122M -8.14B -124M -830M -323M -4.02B -322M -315M -13.89B -5.87M -6.71M -5.41M -5.02M -9.52M -637M -9.68M -64.91M -25.24M -314M -25.2M -24.65M -1.09B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-